These results thus demonstrated for the first time that epacadostat treatment of DCs prior to peptide-pulsing resulted in both increased cytokine production and increased tumor cell lysis by antigen-specific CD8+ T-cell lines derived from cancer patients. The gene discussed is CD8A; the disease is neoplasm.